Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Home

Header Top Menu

  • Careers
  • Investors
  • News
    • Press Release Archive
    • Press Statements
    • Podcasts
      • The Antigen Podcast
      • Get Science Podcast
      • Diverse Perspectives Podcast
      • menopause: unmuted
      • Hemcast
    • Contact Media Relations
    • Press Kits & Downloads
      • Company Press Kit
      • Pfizer Oncology Press Kit
      • PSA Narrative
      • RA NarRAtive
      • Rare Disease Gene Therapy Press Kit
      • ATTR-Amyloidosis Press Kit
      • UC Narrative
      • Eczema Inside Out Press Kit
  • Partners
    • Discovery to Pre-candidate
      • Focus Areas
        • Therapeutic Areas
          • Internal Medicine
          • Inflammation and Immunology
          • Oncology
          • Rare Disease
          • Vaccines
        • Therapeutic Modalities and Technology Platforms
          • Drug Safety
          • Gene Therapy
          • Target Sciences
          • Precision Medicine
          • Medicinal Sciences
            • Biologics Product & Process Development
            • Biotherapeutics Discovery
            • Medicine Design
            • Small Molecule Product & Process Development
        • Emerging Science
          • DNA Damage Response
          • Microsatellite Repeat Expansions
          • Senescence
      • Partnering Models
    • Candidate Through Commercialization
      • Focus Areas
        • Internal Medicine
        • Inflammation and Immunology
        • Oncology
        • Rare Disease
        • Vaccines
        • Hospital
    • Pfizer CentreOne
    • Pfizer Ventures
      • Our portfolio

Healthcare Professionals

  • Healthcare Professionals

Connect with Us

  • Connect with Us
    • Email
    • FAQ
    • Privacy Policy (NEW)
    • YouTube
    • Twitter
    • Facebook
    • LinkedIn
    • Instagram
  • Your Health

    • Healthy Living
      • Brain & Nervous System
      • Cardiovascular Health
      • Cold & Flu
      • Digestive Health
      • Healthier Aging
      • Living Tobacco Free
      • Men’s Health
      • Mental Health
      • Nutrition & Fitness
      • Pediatric Health
      • Respiratory Health
      • Skin Health
      • Vaccines & Prevention
      • Women’s Health

    • Disease & Condition
      • Cancer
      • Cardiovascular Diseases & Conditions
      • Diabetes & Metabolic Disorders
      • Immune System Diseases & Conditions
      • Infections & Infectious Diseases
      • Neurological Diseases & Conditions
      • Menopause
      • Rare Disease
      • Vaccine-Related Conditions
      • Skin Diseases & Conditions
      • Atopic Dermatitis

    • Coronavirus disease (COVID-19)

    • Managing your health
      • Caregiving
      • Evaluating Health Information
      • Tracking Your Health
      • Your Medicines
      • Health Literacy

    • Wellness
    Hot Topics

    Maintaining Emotional Well-Being During COVID-19

    Emotional Well-Being Tips for People Living with Chronic Inflammatory Conditions During COVID-19
  • Our Science

    • Driven to Discover the cure

    • Focus Areas
      • Internal Medicine
      • Inflammation & Immunology
      • Oncology
      • Rare Disease
      • Vaccines
      • Anti Infectives

    • Product Pipeline

    • Clinical Trials
      • Guide to Clinical Trials
      • Find a Trial
      • Expanded Access & Compassionate Use
      • Clinical Trials in Children
      • Partnering with Pfizer
      • Trial Data & Results
      • Research Integrity & Transparency
      • Diversity in Clinical Trials

    • R&D Platforms
      • Biosimilars
      • Gene Therapy
      • Medicinal Sciences
      • Precision Medicine
      • Maternal Immunization

    • Collaboration
      • Partner with Pfizer

    • Research sites

    • Coronavirus disease (COVID-19) Scientific Resources
    HOT TOPICS

    MRNA VS. CONVENTIONAL VACCINES

    What Makes an RNA Vaccine Different From a Conventional Vaccine?
  • Our People

    • Meet The Experts
      • Scientists
      • Internal Medicine – Metabolic Disease
      • Inflammation & Immunology
      • Oncology
      • Rare Disease
      • Vaccines
      • Medical Professionals

    • The Journey

    • Leadership
      • Executives
      • Board Members
      • Company Fact Sheet

    • Diverse Perspectives
      • Diversity & Inclusion
      • Supplier Diversity
    HOT TOPICS

    Meet our new Chief Patient Officer, Dr. Dara Richardson-Heron

    dr_richardson_300x170.jpg

    Working Together to Empower Women

    VizagWomen_300x170.jpg

    • Hot Topics
  • Our Purpose

    • Commitment to Global Health
      • Expanding Access
      • Strengthening Health Systems
      • Providing Disaster & Humanitarian Relief
      • Unleashing the Power of Our Colleagues
      • Highlighting Individual Voices

    • Protecting People and the Environment
      • Pfizer's Green Journey
      • Product Stewardship
      • EHS Governance
      • EHS Supply Chain
      • Key Performance Indicators
      • Health & Safety
      • Human Rights

    • Positions on Health Policies
      • Ready for Cures
      • How does Pfizer price medicines?
      • Value of Medicines
      • Policy Positions
      • Creating Cures Through Facility Investments

    • Transparency
      • Working with Health Care Professionals
      • Transparency in Grants
      • Code of Conduct
      • Corporate Compliance
      • Sales and Marketing Compliance

    • Independent Grants
      • Competitive Grants Program
      • Independent Medical Education
      • Investigator Sponsored Research
      • Quality Improvement
      • COVID-19 Vaccine Grants

    • Contributions & Partnerships
      • Healthcare Charitable Contributions
      • Lobbying & Political Contributions
    HOT TOPICS

    Pfizer Women’s Resource Group

    Media Name: IWD_Pull_up_Banner_300x170.jpg

    • Hot Topics
  • Our Products

    • Product listing

    • How drugs are made
      • Branded vs. Generic
      • Biologics & Biosimilars
      • Commitment to Quality

    • Distributors
      • Pfizer Distributors
      • Greenstone Distributors

    • Medicine Safety
      • Reporting Adverse Events
      • Making Good Treatment Choices
      • Partnering With Patients
      • Health Literacy
      • Medicine Safety Tips for Patients
      • Counterfeiting
      • Unused Medicines

    • Safety Data Sheets

    • Medical Information Contacts

    • Pfizer Global Supply
    HOT TOPICS

    Universal vs. Single Payer Healthcare

    Media Name: universal_healthcare300x170.jpg
  • Careers

    • Working Here
      • Mission & Purpose
      • Culture
      • Diversity & Inclusion
      • Career Growth & Colleague Development
      • Compensation & Benefits
      • Ensuring Corporate Responsibility
    • Search Jobs
    • Student & Early Career
      • Postdoctoral Program
      • US Summer Student Worker Program
      • Opportunities for Veterans
    • Pfizer365.com
    • Our Hiring & Recruiting Process
      • Frequently Asked Questions
      • Tips for Interviewing at Pfizer
    • Connect With Us
  • Investors

    • Investors Overview
      • Why Invest / Our Story
      • Prospective Investors
      • Fact Sheet
    • Events & Presentations
    • Financials
      • Quarterly Reports
      • Annual Reports
      • SEC Filings
      • Interactive Data Filings
    • Investor News
    • Stock Information
      • Historical Price Lookup
      • Investment Calculator
      • Historical Stock Chart & Data
      • Dividend & Split History
      • Stock FAQs
    • Governance
      • Board Committees and Charters
      • The Pfizer Board Policies
      • Corporate Governance FAQs
      • Contact Our Directors
    • Shareholder Services
      • Stock FAQs
      • Advisory Information
      • Cost Basis Calculator
  • News

    • Contact Media Relations
    • Podcasts
    • Press Kits & Downloads
    • Press Release Archive
    • Press Statements
  • Partners
  • Footer links

    • Footer Aside Section1
      • CAREER-SEEKERS
      • INVESTORS
      • News & Media
      • Partners
    • Footer Aside Section 2
      • Healthcare Professionals
      • Business To Business
      • Change Region
      • Sitemap
    • Footer Aside Section3
      • Twitter
      • Facebook
      • Linkedin
      • Instagram
      • Youtube
    • Footer Aside Section4
      • Contact Us
      • Terms of Use
      • Privacy Policy

Celebrating World Patient Safety Day

Celebrating World Patient Safety Day
YOUR HEALTH/ Celebrating World Patient Safety Day
September 16, 2020

World Patient Safety Day recognizes patient safety as a global health priority, a priority that Pfizer is committed to through its global health initiatives. Established in 2019 by the World Health Organization (WHO) and celebrated annually on September 17th1, the focus of this day is to bring together the global community of patients, families, caregivers, health workers, health care leaders, and policymakers to improve patient safety.

“Patient safety is absolutely critical. It is the foundation for everything Pfizer is doing,” said Patrick Caubel, M.D., Chief Safety Officer at Pfizer and a renowned leader in clinical pharmacology and pharmacovigilance. “For over 130 years, taking care of patients and their well-being has been at the core of what we do every day.”

The theme for 2020 is “Health Worker Safety: A Priority for Patient Safety,”3 linking health worker safety with patient safety. As the COVID-19 pandemic has shown, without a safe working environment for health workers, their lives and patients’ lives are at risk.

We spoke with Caubel to learn about the importance of this day and how Pfizer supports this commitment to making health care safer for everyone across the globe.

Why is World Patient Safety Day so important and how has it taken on a new significance during the COVID-19 pandemic?

It was a very good initiative from the WHO to start World Patient Safety Day. Patient safety is not limited to drug safety—it’s different depending on where patients live and the kind of healthcare they have access to. For instance, in developing countries, the lack of appropriate equipment, medication, and even the inappropriate use of drugs causes many hospitalizations and deaths each year.

Because the quality of patient care varies across regions, it’s important for patient safety to be identified and recognized at the global level. In the face of the COVID-19 pandemic, focusing on patient safety resonates now more than ever, as we work to develop a vaccine that is safe and effective.

Why is this year’s theme—Health Worker Safety—so important?

COVID-19 has made it clear that patient safety is inextricably linked with health care worker safety. In the first few months of the pandemic, a lot of health care workers got sick and died from COVID-19 due to a lack of appropriate equipment and protective gear—glasses, gloves, masks. Health care workers are a very important group of people to protect. Not only are they risking their lives to save others -- if we don’t have adequate medical personnel, then there’s nobody available to care for patients.

How has Pfizer supported health workers during COVID-19?

At the start of the pandemic, Pfizer launched our Coronavirus Medical Service Program, to support health systems around the world that were being stretched to the breaking point. In the spring, as a number of health care workers came down with this illness, we saw a unique opportunity for our colleagues to support the medical community in crisis. Through this service program, colleagues who felt called to volunteer their medical skills went into their local communities to diagnose, treat and provide public health support for patients with COVID-19.

Simultaneously, Pfizer and the Pfizer Foundation committed $40 million in medical and charitable cash grants to help combat the global health effects of the COVID-19 pandemic. The donation addressed the urgent needs of partners who are working to slow the spread of the virus within communities, strengthen vulnerable healthcare systems, and help medical centers, hospitals and clinics improve the management and outcomes of patients with COVID-19.

Pfizer’s CEO, along with eight other vaccine manufacturers’ CEOs, recently signed a historic pledge to continue to prioritize the safety and well-being of vaccinated individuals in developing a COVID-19 vaccine. What does that mean for Pfizer’s Worldwide Safety organization?

We are committed to making sure that our resources are dedicated to the discovery, testing, evaluation, and manufacturing of a potential vaccine for COVID-19. The pharmaceutical companies that are involved in COVID-19 vaccine development have been aligned on the same goals from the beginning: apply the best, fair, unbiased medical judgment to the safety of all subjects. This includes public disclosure and applying transparency and fairness to safety evaluation. If people don't trust that the product has been shown to be safe and efficacious, they are less likely to be vaccinated.

The speed at which everybody came together and mobilized—the government, drug industry, and vaccine manufacturers—this is absolutely historic.

You have built your career at Pfizer in Safety Surveillance and Pharmacovigilance, and you were recently named the Chief Safety Officer. What does patient safety mean to you personally?

I’m an OB-GYN by training and also a clinical pharmacologist. After practicing for almost 20 years, I decided to move full-time into drug development and pharmaceutical research. Very quickly I realized that being able to protect patients, to investigate the products that we were developing, was absolutely critical.

For me, taking care of patient safety is the same as if I were personally delivering care to patients. You’re protecting patients who are not your patients, but they’re still patients taking your products. Safety is the most important thing for us to deliver at the end of our research. We have to make sure that we have the safest delivery of care to each and every patient.

To learn more about World Patient Safety Day, click here.

--

Resources:

  1. who.int. World Patient Safety Day, World Health Organization. Available at: https://www.who.int/patientsafety/world-patient-safety-day/en/#:~:text=The%20Seventy%2Dsecond%20World%20Health,observed%20annually%20on%2017%20September. Accessed September 11, 2020.
  2. pfizer.com. The Journey. Available at: https://www.pfizer.com/people/history. Accessed September 14, 2020.
  3. who.int. World Patient Safety Day, World Health Organization. Available at: https://www.who.int/patientsafety/world-patient-safety-day/en/#:~:text=The%20Seventy%2Dsecond%20World%20Health,observed%20annually%20on%2017%20September. Accessed September 11, 2020.

Show
Hide

Footer menu

  • Your Health
    • Healthy Living
    • Disease Conditions
    • Manage Your Health
  • Our Science
    • Therapeutic Areas
    • Product Pipeline
    • Clinical Trials
    • R&D Platforms
    • Collaboration
    • Research SItes
  • Our People
    • Meet the Experts
    • The Journey
    • Leadership
    • Diverse Perspectives
  • Our Purpose
    • Commitment To Global Health
    • Positions on Health Policies
    • Transparency
    • Contributions & Partnerships
  • Our Products
    • Product Listing
    • How Drugs are Made
    • Distributors
    • Global Product Information Contacts

Footer aside

  • Footer Aside Section1
    • CAREER-SEEKERS
    • INVESTORS
    • News & Media
    • Partners
  • Footer Aside Section 2
    • Healthcare Professionals
    • Business To Business
    • Change Region
    • Sitemap
  • Footer Aside Section3
    • Twitter
    • Facebook
    • Linkedin
    • Instagram
    • Youtube
  • Footer Aside Section4
    • Contact Us
    • Terms of Use
    • Privacy Policy
Pfizer Logo Footer

Copyright © 2002-2021 Pfizer Inc. All rights reserved. This information—including product information—is intended only for residents of the United States.
The products discussed herein may have different labeling in different countries.